Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 21 - 30 of 31 results
-
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
Date:
04/17/2021Topics:
Lead Investigators:
-
Ancillary Studies of NAFLD and NASH in HIV infected Adults
Date:
02/01/2021Topics:
Lead Investigators:
-
A Phase 2 Randomized, Open-label, Parallel-group, Multicenter Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Response to Combination Regimens Containing JNJ-73763989 and Nucleos(t)Ide Analog With or Without JNJ-56136379 in Patients With Chronic Hepatitis B Virus Infection
Date:
02/01/2021Topics:
Lead Investigators:
-
Johns Hopkins University Baltimore - India Clinical Trials Unit (JHUBI CTU)
Date:
12/01/2020Lead Investigators:
-
ABI-H2158-201: A Phase 2a, Multi-Center, Single-Blind, Placebo-Controlled, Multiple Cohort Study Evaluating ABI-H2158-Containing Regimens in Chronic Hepatitis B Infection
Date:
07/01/2020Topics:
Lead Investigators:
-
Opioid Use Disorder Treatment Linkage at STD Clinics (OUTLAST-B)
Date:
04/15/2019Locations:
Lead Investigators:
-
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation
Date:
08/01/2018Locations:
Lead Investigators:
-
Pritelivir versus foscarnet for acyclovir-resistant mucocutaneous HSV infections in immunocompromised adults (PRIOH-1)
Date:
07/01/2017Locations:
Lead Investigators:
-
Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Date:
01/01/2017Locations:
Lead Investigators:
-
Strategies to improve the HIV care continuum among key populations in India
Date:
09/30/2015Locations:
Lead Investigators: